Immune checkpoint inhibitors in hepatocellular cancer patient with congenital haemophilia A

J Gastrointestin Liver Dis. 2022 Jun 12;31(2):258-259. doi: 10.15403/jgld-4342.
No abstract available

Publication types

  • Letter

MeSH terms

  • Carcinoma, Hepatocellular* / drug therapy
  • Hemophilia A* / complications
  • Hemophilia A* / diagnosis
  • Hemophilia A* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors
  • Liver Neoplasms* / drug therapy

Substances

  • Immune Checkpoint Inhibitors